Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:appointed_by |
topical solution
|
| gptkbp:composed_of |
natural sources
|
| gptkbp:developed_by |
Podophyllum peltatum
mayapple |
| gptkbp:environmental_impact |
human cells
|
| https://www.w3.org/2000/01/rdf-schema#label |
podophyllotoxin
|
| gptkbp:ingredients |
C22 H22 O8
|
| gptkbp:is_available_on |
prescription medication
|
| gptkbp:is_considered_as |
potential therapeutic agent
|
| gptkbp:is_known_for |
antiviral properties
|
| gptkbp:is_noted_for |
inhibiting cell division
|
| gptkbp:is_part_of |
plant secondary metabolites
|
| gptkbp:is_related_to |
gptkb:etoposide
|
| gptkbp:is_studied_in |
HIV treatment
|
| gptkbp:is_used_for |
warts treatment
|
| gptkbp:is_used_in |
chemotherapy
|
| gptkbp:scientific_classification |
gptkb:drug
|
| gptkbp:targets |
topoisomerase II
|
| gptkbp:type_of |
antineoplastic agent
|
| gptkbp:used_in |
gptkb:healthcare_organization
|
| gptkbp:weight |
414.41 g/mol
|
| gptkbp:bfsParent |
gptkb:etoposide
|
| gptkbp:bfsLayer |
5
|